Biosortia Microbiomics Company
Biosortia works on new drugs from deep access to the chemistry of the microbiome for immuno-oncology and immunological therapeutics.
Technology:
Artificial Intelligence, Biotechnology, Pharmaceutical
Industry:
AI, Early Drug Development, Preclinical Development, United States
Headquarters:
Dublin, Ohio, United States
Founded Date:
2012-01-01
Employees Number:
11-50
Funding Status:
Seed
Investors Number:
1
Total Funding:
22035000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2017-10-01
Last Funding Type:
Seed
Register and Claim Ownership